Lack of National Data Registry
Without a central registry, Malaysia has no accurate count of patients, disease types, or prevalence, making planning and support difficult.
Limited Awareness and Understanding
Many Malaysians are unfamiliar with rare diseases, causing misunderstandings and delay in seeking help.
Delayed or Misdiagnosis
Many general practitioners and physicians have limited exposure to rare diseases, making them less familiar with the signs and symptoms.
Lack of Specialists
Malaysia has very few geneticists, metabolic specialists, and genetic counselors, making access to expert care extremely limited.
Limited Funding for Screening and Treatment
Treatment and diagnostic tests are costly, but public funding is limited, leaving many families to rely on NGOs or personal savings.
Restricted Access to Treatment and Medication
Some therapies are unavailable or not covered in Malaysia, forcing patients to travel abroad or go without essential care.
Insufficient Research and Local Studies
With few research initiatives and limited data, understanding of Malaysia’s rare disease landscape remains shallow — affecting policy, planning, and early intervention.
Stigma and Social Misunderstanding
Many rare diseases are invisible or misunderstood, causing patients to face judgment, social isolation, or assumptions about their abilities.